(Q44220773)

1 December 2017

1 reference

title

HIV-2 and T cell recognition (English)

1 reference

1 December 2017

Whittle HC

1

1 reference

1 December 2017

Ariyoshi K

series ordinal

2

1 reference

1 December 2017

Rowland-Jones S

series ordinal

3

1 reference

1 December 2017

language of work or name

1 reference

1 August 1998

1 reference

Current Opinion in Immunology

1 December 2017

published in

1 reference

1 December 2017

volume

10

1 reference

1 December 2017

issue

4

1 reference

1 December 2017

page(s)

382-387

1 reference

Isolation of a new human retrovirus from West African patients with AIDS.

1 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

Prevalence of and mortality from human immunodeficiency virus type 2 in Bissau, West Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

The epidemiology of HIV infection in a rural area of Guinea-Bissau.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

Lessons from the second AIDS virus, HIV-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

Slower heterosexual spread of HIV-2 than HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

HIV-2-infected patients survive longer than HIV-1-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

Reduced rate of disease development after HIV-2 infection as compared to HIV-1

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

The effects of HIV-2 infection in a rural area of Guinea-Bissau.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

Cellular and plasma viral load in patients infected with HIV-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

Clinical and laboratory predictors of survival in Gambian patients with symptomatic HIV-1 or HIV-2 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

9-year HIV-2-associated mortality in an urban community in Bissau, west Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

Two-year HIV-1-associated mortality in a Ugandan rural population

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

A community-based study of human immunodeficiency virus type 2 provirus load in rural village in West Africa

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

Natural protection against HIV-1 infection provided by HIV-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

Cytotoxic T cells from human immunodeficiency virus type 2-infected patients frequently cross-react with different human immunodeficiency virus type 1 clades

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

Isolation and characterization of a novel protein (X-ORF product) from SIV and HIV-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

The human immunodeficiency virus type 1 (HIV-1) Vpu protein interferes with an early step in the biosynthesis of major histocompatibility complex (MHC) class I molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

Genome organization and transactivation of the human immunodeficiency virus type 2.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

HIV type 2 pathogenicity is not related to subtype in rural Guinea Bissau

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

Genetic subtypes of HIV type 1 and HIV type 2 strains in commercial sex workers from Bamako, Mali.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

Evasion of cytotoxic T lymphocyte (CTL) responses by nef-dependent induction of Fas ligand (CD95L) expression on simian immunodeficiency virus-infected cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

Protective effects of a live attenuated SIV vaccine with a deletion in the nef gene

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

Evidence of Nef truncation in human immunodeficiency virus type 2 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

Differential regulation of human immunodeficiency viruses (HIVs): a specific regulatory element in HIV-2 responds to stimulation of the T-cell antigen receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

Differential activation of human immunodeficiency virus type 1 and 2 transcription by specific T-cell activation signals.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

Replicative capacity of HIV-2, like HIV-1, correlates with severity of immunodeficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

Biological phenotype of HIV type 2 isolates correlates with V3 genotype.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

A broad range of chemokine receptors are used by primary isolates of human immunodeficiency virus type 2 as coreceptors with CD4.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

Intrapatient Variability of the Human Immunodeficiency Virus Type 2 Envelope V3 Loop

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

Cross-neutralization of human immunodeficiency virus type 1 and 2 and simian immunodeficiency virus isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

Autologous neutralizing antibodies prevail in HIV-2 but not in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

Broadly reactive HIV-2 and SIVmac specific antibody-dependent cellular cytotoxicity in immunized and infected cynomolgus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

Rate of decline of percentage CD4+ cells is faster in HIV-1 than in HIV-2 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

T-helper cross reactivity to viral recombinant proteins in HIV-2-infected patients

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

T-helper reactivity to simian immunodeficiency virus gag synthetic peptides in human immunodeficiency virus type 2 infected individuals.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

Vigorous HIV-1-specific CD4+ T cell responses associated with control of viremia

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

Studies in subjects with long-term nonprogressive human immunodeficiency virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

Virologic and immunologic characterization of long-term survivors of human immunodeficiency virus type 1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

Analysis of lymphocyte cell death and apoptosis in HIV-2-infected patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

T cell apoptosis in human immunodeficiency virus type 2- and simian immunodeficiency virus-infected macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

HIV-2-specific cytotoxic T-lymphocyte activity is inversely related to proviral load

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

An HIV-1 and HIV-2 cross-reactive cytotoxic T-cell epitope

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

Human immunodeficiency virus genetic variation that can escape cytotoxic T cell recognition

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

Identification of overlapping HLA class I-restricted cytotoxic T cell epitopes in a conserved region of the human immunodeficiency virus type 1 envelope glycoprotein: definition of minimum epitopes and analysis of the effects of sequence variation

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

Recognition of a highly conserved region of human immunodeficiency virus type 1 gp120 by an HLA-Cw4-restricted cytotoxic T-lymphocyte clone

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

Distinct recognition of closely-related HIV-1 and HIV-2 cytotoxic T-cell epitopes presented by HLA-B*2703 and B*2705.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

Cross-clade recognition of p55 by cytotoxic T lymphocytes in HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

Major expansion of CD8+ T cells with a predominant V beta usage during the primary immune response to HIV.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

Superinfection with human immunodeficiency virus type 2 can reactivate virus production in baboons but is contained by a CD8 T cell antiviral response.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

HIV-2 and natural protection against HIV-1 infection

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

HIV-1 recombinant poxvirus vaccine induces cross-protection against HIV-2 challenge in rhesus macaques

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

Long–term protection against SIV–induced disease in macaques vaccinated with a live attenuated HIV–2 vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

Protection of human immunodeficiency virus type 2-exposed seronegative macaques from mucosal simian immunodeficiency virus transmission.

1 reference

https://api.crossref.org/works/10.1016%2FS0952-7915%2898%2980108-8

7 January 2021

10.1016/S0952-7915(98)80108-8

Identifiers

DOI

1 reference

1 December 2017

1 reference